MILLENDO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On January 5, 2021, the Company issued a press release announcing an expansion of the Company's pursuit of strategic alternatives and a discontinuation of the development of MLE-301. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits



Exhibit
No.        Description

  99.1       Press Release dated January 5, 2021

© Edgar Online, source Glimpses